
Core Insights - Chemung Financial reported revenue of $25.88 million for the quarter ended December 2024, reflecting an 8.9% increase year-over-year [1] - The company's EPS was $1.24, up from $0.81 in the same quarter last year, exceeding the consensus estimate of $1.23 [1] - The revenue surpassed the Zacks Consensus Estimate of $25.04 million, resulting in a surprise of +3.34% [1] Financial Performance Metrics - Net Interest Margin was reported at 2.9%, above the average estimate of 2.8% from two analysts [4] - Efficiency Ratio stood at 68.9%, compared to the average estimate of 67.2% from two analysts [4] - Net Interest Income reached $19.82 million, exceeding the average estimate of $19.14 million from two analysts [4] - Total non-interest income was $6.06 million, surpassing the estimated $5.90 million from two analysts [4] - Net gain on sales of loans held for sale was $0.05 million, below the average estimate of $0.10 million from two analysts [4] Stock Performance - Chemung Financial's shares have returned -4.7% over the past month, while the Zacks S&P 500 composite increased by +0.8% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]